Cell : The Lancet - Translational Medicine

Speaker

Gustavo DONCEL, CONRAD, Arlington, USA

Gustavo DONCELDr. Doncel is the Scientific and Executive Director of CONRAD, a U.S. program focused on developing new technologies in HIV/AIDS prevention and Reproductive Health. CONRAD exists to facilitate the rapid development of safe, acceptable, affordable products and methods that provide contraception and/or prevent the sexual transmission of HIV/AIDS and other infections. Dr. Doncel is also Professor of Obstetrics and Gynecology and directs the Microbicide and Contraceptive Research Laboratory at Eastern Virginia Medical School (EVMS). His lab currently focuses on:
i) Discovery and preclinical characterization of novel, anti-HIV/STI, topical microbicides and multipurpose prevention technologies in reproductive health, and
ii) Characterization of biological, molecular and genomic markers of cervicovaginal inflammation – Impact of microbicides and reproductive hormones. Dr. Doncel received his M.D. degree from the University of Buenos Aires, Argentina, in 1983. After obtaining his Ph.D. degree, he completed a postdoctoral training on reproductive immunology at EVMS under a fellowship of the U.S. Agency for International Development (USAID). He then joined the faculty of EVMS in 1992. Dr. Doncel has authored more than 100 scientific publications in the areas of microbicides, anti-HIV drugs, contraception, sperm biology, and reproductive immunology. He is a grant proposal reviewer for national and international organizations such as the National Institute of Allergy and Infectious Diseases (NIAID), the World Health Organization (WHO), the European Community (EC), and the Bill and Melinda Gates Foundation. Dr. Doncel serves as a scientific advisor for various research projects and organizations focused on biomedical HIV prevention efforts and drug development. He is also a member of the recently created WHO Task Force on Hormonal Contraception and HIV-1 infection. He is the principal investigator of ongoing research projects, totaling more than $140M, on women’s health issues related to HIV/STI prevention and family planning.  

« Go Back

Organized by

Elsevier
Journal - The Lancet
Journal - Cell
Elsevier

Partners

Timothy Ray Brown
World AIDS Institute